H. Ç. YILDIRIM Et Al. , "A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer," Anti-cancer drugs , vol.34, no.10, pp.1190-1192, 2023
YILDIRIM, H. Ç. Et Al. 2023. A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer. Anti-cancer drugs , vol.34, no.10 , 1190-1192.
YILDIRIM, H. Ç., Ismayilov, R., AKYILDIZ, A., GÜVEN, D. C., Abdurrahimli, N., DİZDAR, Ö., ... YALÇIN, Ş.(2023). A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer. Anti-cancer drugs , vol.34, no.10, 1190-1192.
YILDIRIM, HASAN Et Al. "A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer," Anti-cancer drugs , vol.34, no.10, 1190-1192, 2023
YILDIRIM, HASAN Ç. Et Al. "A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer." Anti-cancer drugs , vol.34, no.10, pp.1190-1192, 2023
YILDIRIM, H. Ç. Et Al. (2023) . "A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer." Anti-cancer drugs , vol.34, no.10, pp.1190-1192.
@article{article, author={HASAN ÇAĞRI YILDIRIM Et Al. }, title={A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer}, journal={Anti-cancer drugs}, year=2023, pages={1190-1192} }